Lai Xue-Li, Wang Hai-Yan, Guo Zhi-Yong
Department of Nephrology, Shanghai Changhai Hospital, Shanghai 200433, China.
Chronic Dis Transl Med. 2020 May 4;6(2):115-118. doi: 10.1016/j.cdtm.2020.04.003. eCollection 2020 Jun.
The World Health Organization characterized coronavirus disease (COVID-19) as a pandemic on March 11, 2020. Peritoneal dialysis patients have a weakened immune system that is associated with a high morbidity of infection. Thus, COVID-19 prevention measures and management for patients on peritoneal dialysis are urgent and critical. Based on published research on COVID-19 and previous clinical practices for similar coronavirus outbreaks, we aimed to make recommendations to manage patients undergoing peritoneal dialysis.
2020年3月11日,世界卫生组织将冠状病毒病(COVID-19)列为大流行病。腹膜透析患者免疫系统较弱,感染发病率较高。因此,针对腹膜透析患者的COVID-19预防措施和管理措施迫在眉睫且至关重要。基于已发表的关于COVID-19的研究以及以往应对类似冠状病毒爆发的临床实践,我们旨在为管理接受腹膜透析的患者提供建议。